-
Entity
-
Individual
-
Location
-
C/O Ideaya Biosciences, Inc., 7000 Shoreline Court, Suite 350, South San Francisco, CA
-
Summary
-
The estimated net worth of Mark Lackner is at least $878K dollars as of February 5, 2025. Mark Lackner is the Chief Scientific Officer of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $878K.